focus mul - UKSH Universitätsklinikum Schleswig-Holstein

06. Lamprecht P, Gutzeit O, Csernok E, Gause A, Longombardi G, Zignego AL,
Gross WL, Ferri C (2003) Prevalence of ANCA in mixed cryoglobulinemia
and chronic hepatitis C virus infection. Clin Exp Rheumatol 21: S89-S94
07. Lamprecht P, Lerin-Lozano C, Merz H, Dennin RH, Gause A, Voswinkel J,
Peters SO, Gutzeit O, Arlt AC, Solbach W, Gross WL (2003) Rituximab
induces remission in refractory HCV associated cryoglobulinaemic
vasculitis. Ann Rheum Dis 62:1230-1233
08. Lamprecht P, Vargas Cuero A, Müller A, Csernok E, Voswinkel J, Maass M,
Solbach W, Gross WL, Klenerman P (2003) Alterations in the phenotype
of CMV-specific and total CD8+ T populations in Wegener's granulomatosis.
Cell Immunol 224:1-7
09. Lamprecht P, Voswinkel J, Gause A, Gross WL (2003) Infliximab efficiency in
refractory Wegener's granulomatosis. (letter). Rheumatology 42:1125-
1126
10. Lamprecht P, Voswinkel J, Gause A, Gross WL (2003) Reply. Effectiveness
of TNF-alpha blockade with Iinfliximab in refractory Wegener's
granulomatosis. (letter). Rheumatology 42:1125-1126
11. Linder R, Reinhold-Keller E, Gross WL (2003) Use of an artificial neural
network to predict cancer development in patients with inflammatory
myopathy: comment on the letter by Selva O'Callaghan et al. Arthritis
Rheum 48:1168-9; author reply 1169-1170
12. Meyer M, Menken K, Zimny S, Hellmich B, Schatz H (2003) Pitfall in
diangosing growth hormone deficiency in a hypochondroplastic patient
with a delayed puberty. Exp Clin Endocrinol Diabetes 111:177-181
13. Reichel PH, Seemann C, Csernok E, Schröder JM, Muller A, Gross WL,
Schultz H (2003) Bactericidal/Permeability-increasing protein is expressed
by human dermal fibroblasts and upregulated by interleukin 4. Clin Diagn
Lab Immunol 10:473-475
14. Schnabel A, Reuter M, Biederer J, Richter C, Gross WL (2003) Interstitial lung
disease in polymyositis and dermatomyositis: clinical course and response
to treatment. Semin Arthritis Rheum 32:273-284
15. Schultz H, Csernok E, Herlyn K, Reichel PH, Moosig F, Cornely A, Fagerhol
M, Gross WL (2003) ANCA against Bactericidal/ Permeability-increasing
Protein, Azurocidin, Calprotectin and Defensins in rheumatic and
infectious diseases: prevalence and clinical associations. Clin Exp
Rheumatol: 21: S117-S120
16. Schultz H, Heintz H, van Zandbergen G, Ullrich S, Reinhold-Keller E, Gross
WL (2003) ANCA against the bactericidal/permeability increasing protein
(BPI-ANCA) can compromise the antibiotic function of BPI in a Wegener's
granulomatosis patient. Clin Exp Rheumatol: 21: 763-766
17. Schultz H, Schinke S, Weiss J, Cerundolo V, Gross WL, Gadola S (2003)
BPI-ANCA in transporter associated with antigen presentation (TAP)
deficiency: possible role in susceptibility to Gram-negative bacterial
infections. Clin Exp Immunol 133:252-259
478